The Diagnostic and Therapeutic Challenges of A Progressive Male Breast Cancer with Brain Metastases: A Case Report
DOI:
https://doi.org/10.26911/theijmed.2016.1.2.927Abstract
Background: Male breast cancer (MBC) is a rare malignancy that is often associated with advanced stages and poor prognosis due to lack of public awareness and early screening, along with stigmatization of the disease. Aims: This case report aims to highlight the diagnostic and therapeutic challenges of rapidly-progressive MBC in resource-limited healthcare, particularly those compounded by systemic and patient-attributable delays, and emphasize the importance of prevention and early detection of breast cancer in the male population.
Subject report: We report the case of a 71-year-old man with a three-month history of a progressively enlarging lump on right breast, weight loss, and right-sided hemiparesis. Medical history included chronic heart failure, dyslipidemia, heavy smoking, and labour work background. The diagnosis of invasive ductal breast carcinoma was established through clinical assessment, imaging, and biopsy.
Results: The patient underwent primary tumor resection (PTR) in the form of radical mastectomy, where the main purpose was tumor debulking, revealing tumor invasion into the pectoralis major muscle (pT4 disease). The clinical course was severely impacted by Treatment Delay, encompassing Provider Delay and Patient Delay, which was caused by logistical, operational, and policy barriers. This delay critically postponed the scheduled non-contrast computed tomography (CT) of the head. The delayed CT subsequently revealed multiple metastases. The patient was then referred for immunohistochemistry (IHC) evaluation and systemic therapies but passed away before the scheduled workup due to a declining neurological state from confirmed brain metastases.
Conclusion: This case underscores how the challenges of rapidly progressive MBC with brain metastases, combined with a variety of delays and constrained treatment options, resulted in a poor outcome. It highlights the critical need for increased awareness, stigma reduction, and streamlined resource pathways to improve early detection and timely intervention in resource-limited settings.
Keywords:
Breast cancer, Male, Treatment Delays, Metastases, Breast cancer, Male, Treatment Delays, MetastasesReferences
Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKenna WG (2020). Abeloff's clinical oncology. 6th ed. Philadelphia: Elsevier.
Agustina SA, Barokah L (2019). Correlation between obesity and contraceptive method on estrogen and progesterone receptors and human epidermal growth factor receptor-2 expression among breast cancer patients in Dr. Moewardi Hospital, Surakarta. Indones J Med. 4(3): 259–265. doi:10.26911/theijmed.2019.04.03.09
Alfaini F, Rafli R, Oktara MZ (2024). Factors causing diagnostic delay and treatment delay patient breast cancer in Universitas Andalas Hospital. Indones J Cancer. 18(3): 253–260. doi:10.33371/ijoc.v18i3.1072.
AlFehaid M (2023). Male breast cancer (MBC): a review. Pol Przegl Chir. 95(6): 24–30. doi:10.5604/01.-3001.0016.3174.
Alharbi KS, Almalki WH, Makeen HA, Albratty M, Meraya AM, Nagraik R, Sharma A, et al. (2022). Role of medicinal plant-derived nutra-ceuticals as a potential target for the treatment of breast cancer. J Food Biochem. 46(12). doi:10.1111/jfbc.-14387.
Alkhaifi M, Clayton A, Kishibe T, Simpson JS (2022). The association between smoking status and breast cancer recurrence: a systematic review. J Breast Cancer. 25(4): 278. doi:10.-4048/jbc.2022.25.e23.
Arabshahi SKS, Nikjoo S, Rezapour A, Kemmak AR, Jahangiri R, Farabi H, Barghzan S, et al. (2022). Economic evaluation of palliative care for patients with cancer disease: a systematic review. Med J Islam Repub Iran. 36(1). doi:10.47176/mjiri.36.141.
Brierley JD, Giuliani M, O'Sullivan B, Rous B, Van Eycken E (2025). TNM classification of malignant tumours. 9th ed. Hoboken: John Wiley & Sons.
Chen WL, Lin GL, Lin YJ, Su TY, Wang CC, Wu WT (2023). Cancer risks in a population-based study of agricultural workers: results from the Taiwan's farmers and health cohort study. Scand J Work Environ Health. 49(6): 419–427. doi:10.5271/sjweh.4106.
Co M, Lee A, Kwong A (2020). Delayed presentation, diagnosis, and psycho-social aspects of male breast cancer. Cancer Med. 9(10): 3305–3309. doi:10.1002/cam4.2953.
Doehner W, Böhm M, Boriani G, Christersson C, Coats AJS, Haeusler KG, Jones ID, et al. (2023). Interaction of heart failure and stroke: a clinical consensus statement of the ESC Council on Stroke, the Heart Failure Association (HFA) and the ESC Working Group on Thrombosis. Eur J Heart Fail. 25(12): 2107–2129. doi:10.1002/ejhf.3071.
El Saghir NS, Adebamowo CA, Anderson BO, Carlson RW, Bird PA, Corbex M, Badwe RA, et al. (2011). Breast cancer management in low resource countries (LRCs): consensus state-ment from the Breast Health Global Initiative. Breast. 20(Suppl 2). doi:10.1016/j.breast.2011.02.006.
Emos MC, Rosner J (2023). Neuro-anatomy, upper motor nerve signs. In: StatPearls. Treasure Island (FL): StatPearls Publishing.
Fentiman IS (2022). Male breast cancer. In: Oncoplastic breast surgery. Boca Raton: CRC Press. p. 312–314. doi:10.1201/9781315115146-70.
Gondhowiardjo S, Hartanto S, Wirawan S, Jayalie VF, Astiti IAP, Panigoro SS, Sekarutami SM, et al. (2021). Treatment delay of cancer patients in Indonesia: a reflection from a national referral hospital. Med J Indones. 30(2): 129–137. doi:10.13181/mji.oa.204296.
Hanna TP, King WD, Thibodeau S, Jalink M, Paulin GA, Harvey-Jones E, O'Sullivan DE, et al. (2020). Mortality due to cancer treatment delay: systematic review and meta-analysis. BMJ. 371: m4087. doi:10.1136/bmj.m4087.
Hutajulu SH, Prabandari YS, Bintoro BS, Wiranata JA, Widiastuti M, Suryani ND, Saptari RG, et al. (2022). Delays in the presentation and diagnosis of women with breast cancer in Yogyakarta, Indonesia: a retrospective observational study. PLoS One. 17(1). doi:10.1371/journal.pone.0262468.
Katsura C, Ogunmwonyi I, Kankam HK, Saha S (2022). Breast cancer: presentation, investigation and management. Br J Hosp Med (Lond). 83(2): 1–7. doi:10.12968/hmed.20-21.0459.
Kesireddy M, Elsayed L, Shostrom VK, Agarwal P, Asif S, Yellala A, Krishnamurthy J (2024). Overall survival and prognostic factors in metastatic triple-negative breast cancer: a national cancer database analysis. Cancers (Basel). 16(10). doi:10.3390/cancers16101791.
Ketaren ES, Murti B, Widyaningsih V (2021). Meta-analysis of the effect of physical activity on survival in breast cancer patients. Indones J Med. 6(1): 32–41. doi:10.26911/theijmed.2021.-06.01.04.
Khan NAJ, Tirona M (2021). An updated review of epidemiology, risk factors, and management of male breast cancer. Med Oncol. 38(4): 39. doi:10.1007/s12032-021-01486-x.
Khan SA, Zhao F, Goldstein LJ, Cella D, Basik M, Golshan M, Julian TB, et al. (2022). Early local therapy for the primary site in de novo stage IV breast cancer: results of a randomized clinical trial (E2108). J Clin Oncol. 40(9): 978–987. doi:10.1200/JCO.21.02006.
Khare VS, Huda F, Misra S, Amulya KR, Raj N, Karn S, Basu S (2024). Male breast cancer: an updated review of patient characteristics, genetics, and outcome. Int J Breast Cancer. 2024: 9003572. doi:10.1155/2024/9003572.
Kim HY, Lee S, Kim D, Jung CS, Kim JY, Nam KJ, Choo KS, et al. (2022). Male metaplastic breast cancer with poor prognosis: a case report. World J Clin Cases. 10(15): 4964–4970. doi:10.12998/wjcc.v10.i15.4964.
Kumar V, Abbas AK, Aster JC, Deyrup AT (2022). Robbins & Kumar basic pathology. 10th ed. Philadelphia: Elsevier.
Kumar R, Schonfeld R, Lurie RH, Moran MS, Abraham J, Abramson V, Aft R, et al. (2024). NCCN clinical practice guidelines in oncology: breast cancer. Version 1.2024. Plymouth Meeting, PA: National Comprehensive Cancer Network.
Landrigan PJ, Raps H, Cropper M, Bald C, Brunner M, Canonizado EM, Charles D, et al. (2023). The Minderoo-Monaco Commission on plastics and human health. Ann Glob Health. 89(1). doi:10.5334/aogh.4056.
Li N, Wang X, Zhang H, Wang H (2018). Young male breast cancer, a small crowd, the survival, and prognosis? A population-based study. Medicine (Baltimore). 97(40). doi:10.1097/-MD.0000000000012686.
Madeira M, Mattar A, Passos RJB, Mora CD, Mamede LHBV, Kishino VH, Torres TZM, et al. (2011). A case report of male breast cancer in a very young patient: what is changing? World J Surg Oncol. 9(1): 16. doi:10.1186/1477-7819-9-16.
Mathew J, Perkins GH, Stephens T, Middleton LP, Yang WT (2008). Primary breast cancer in men: clinical, imaging, and pathologic findings in 57 patients. AJR Am J Roentgenol. 191(6): 1631–1639. doi:10.2214/AJR.08.1076.
Mattei P, Chang B (2022). Chest wall tumors. In: Fundamentals of pediatric surgery. Cham: Springer International Publishing. p. 1061–1064. doi:10.1007/978-3-031-07524-7_116.
Midding E, Halbach SM, Kowalski C, Weber R, Würstlein R, Ernstmann N (2018). Men with a woman's disease: stigmatization of male breast cancer patients—a mixed methods analysis. Am J Mens Health. 12(6): 2194–2207. doi:10.1177/1557988318799025.
Nowinski WL (2024). Taxonomy of acute stroke: imaging, processing, and treatment. Diagnostics (Basel). 14(10). doi:10.3390/diagnostics1410-1057.
Pensabene M, Von Arx C, De Laurentiis M (2022). Male breast cancer: from molecular genetics to clinical management. Cancers (Basel). 14(8): 2006. doi:10.3390/cancers14082006.
Rivera AM, Espinoza SL, Aguilar RM, Palencia R (2017). Male breast cancer: case report. Rev Colomb Radiol. 28(4): 4810–4815.
Santoso H (2024). The right of the hospital to cooperate with the social security organizing body for health in health services. J Hukum Indones. 3(1): 29–38. doi:10.58344/jhi.v3i1.675.
Sari RK, Abdurrahman M, Soemitro MP, Rizki KA, Yohana R (2023). Male breast cancer in Dr. Hasan Sadikin General Hospital: a serial case. Bioscientia Med. 7(7): 3445–3452. doi:10.37275/bsm.v7i7.843.
Silva E, Meschter S, Tan MP (2023). Breast biopsy techniques in a global setting: clinical practice review. Transl Breast Cancer Res. 4: 14. doi:10.21037/tbcr-23-12.
Soran A, Ozmen V, Ozbas S, Karanlik H, Muslumanoglu M, Igci A, Canturk Z, et al. (2018). Randomized trial comparing resection of primary tumor with no surgery in stage IV breast cancer at presentation: protocol MF07-01. Ann Surg Oncol. 25(11): 3141–3149. doi:10.1245/s10434-018-6494-6.
Stephens JA, Fisher JL, Wesolowski R, Paskett ED (2023). Missing components of receptor status among women with invasive breast cancer. JAMA Netw Open. 6(8): e2330791. doi:10.1001/jamanetworkopen.2023.30791.
Tamburaka S, Purnaman SMN, Samawi A, Fauziah VD (2024). The analysis of revenue accounting regarding the BPJS health insurance payment system in a regional general hospital. J Akunt Keuang. 10(1): 90. doi:-10.33772/jakuho.v10i1.
Wati W, Mudigdo A, Qadrijati I (2019). Factors associated with late detection of breast cancer: application of health belief model theory. Indones J Med. 4(2): 105–115. doi:10.26911/-theijmed.2019.04.02.04.
Wu C, Li X, Liu S, Yao L, He T, Wang Y, Dong H, et al. (2024). Primary tumor resection in de novo metastatic breast cancer from an oligometastatic perspective: a systematic review and meta-analysis. iScience. 27(12). doi:10.1016/j.isci.2024.111224.
Zhao L, Cheng H, He D, Zhang Y, Chai Y, Song A, Sun G (2025). Decoding male breast cancer: epidemiological insights, cutting-edge treatments, and future perspectives. Discov Oncol. 16(1). doi:10.1007/s12672-025-02140-y.
